Fat cells allow melanoma cells to penetrate the dermis, from which they spread, causing fatal metastases in vital organs, TAU researchers say
Researchers at Tel Aviv University, led by Prof. Carmit Levy and Dr. Tamar Golan of the Department of Human Genetics and Biochemistry at TAU’s Sackler School of Medicine, have discovered that fat cells are involved in the transformation that melanoma cells undergo from cancer cells of limited growth in the epidermis to lethal metastatic cells attacking patients’ vital organs.
“We have answered a major question that has preoccupied scientists for years,” explains Prof. Levy. “What makes melanoma change form, turning aggressive and violent? Locked in the skin’s outer layer, the epidermis, melanoma is very treatable; it is still Stage 1, it has not penetrated the dermis to spread through blood vessels to other parts of the body and it can simply be removed without further damage.
“Melanoma turns fatal when it ‘wakes up,’ sending cancer cells to the dermis layer of skin, below the epidermis, and metastasizing in vital organs. Blocking the transformation of melanoma is one of the primary targets of cancer research today, and we now know fat cells are involved in this change.””
The research was conducted in collaboration with several senior pathologists: Dr. Hanan Vaknin of Wolfson Medical Center, and Dr. Dov Hershkowitz and Dr. Valentina Zemer of Tel Aviv Medical Center.
The study was on published July 23 in Science Signaling and is featured on the journal’s cover.
In the study, the researchers examined dozens of biopsy samples taken from melanoma patients at Wolfson Medical Center and Tel Aviv Medical Center, and observed a suspicious phenomenon: fat cells near the tumor sites.
“We asked ourselves what fat cells were doing there and began to investigate,” adds Prof. Levy. “We placed the fat cells on a petri dish near melanoma cells and followed the interactions between them.”
The researchers observed fat cells transferring proteins called cytokines, which affect gene expression, to the melanoma cells.
“Our experiments have shown that the main effect of cytokines is to reduce the expression of a gene called miRNA211, which inhibits the expression of a melanoma receptor of TGF beta, a protein that is always present in the skin,” says Prof. Levy. “The tumor absorbs a high concentration of TGF beta, which stimulates melanoma cells and renders them aggressive.”
Critically, the researchers have also found a way to block this transformation.
“It is important to note that we found the process reversible in the laboratory: When we removed the fat cells from the melanoma, the cancer cells calmed down and stopped migrating,” adds Prof. Levy.
A trial of mouse models of melanoma yielded similar results: When miRNA211 was repressed, metastases were found in other organs, while re-expressing the gene blocked metastases formation.
In the search for a potential drug based on the new discovery, the researchers experimented with therapies that are known to inhibit cytokines and TGF beta, but which have never before been used to treat melanoma.
“We are talking about substances that are currently being studied as possible treatments for pancreatic cancer, and are also in clinical trials for prostate, breast, ovarian and bladder cancers,” Dr. Golan said. “We saw that they restrained the metastatic process, and that the melanoma returned to its relatively ‘calm’ and dormant state.”
“Our findings can serve as a basis for the development of new drugs to halt the spread of melanoma — therapies that already exist, but were never used for this purpose,” concludes Prof. Levy. “In the future, we are seeking to collaborate with drug companies to enhance the development of the metastatic melanoma prevention approach.”
The Latest on: Melanoma
via Google News
The Latest on: Melanoma
- Sharp declines in melanoma mortality 'unprecedented in cancer medicine'on March 20, 2020 at 11:23 am
The introduction and approval of new treatments for metastatic melanoma has led to significant declines in population-level mortality over the past several years, according to results of a ...
- Large decrease seen in melanoma mortality from 2013 to 2016on March 20, 2020 at 8:01 am
(HealthDay)—From 2013 to 2016, there was a large decrease of 17.9 percent in melanoma mortality, according to a study published online March 19 in the American Journal of Public Health. Juliana ...
- New melanoma treatments reduce deaths from skin canceron March 20, 2020 at 12:49 am
New treatments for melanoma have dramatically reduced deaths from this often fatal skin cancer. Leaders of a new study report that the death rate from aggressive melanoma that spread to other organs ...
- U.S. Sees Big Drop in Deaths From Melanomaon March 19, 2020 at 2:03 pm
THURSDAY, March 19, 2020 (HealthDay News) -- New treatments for melanoma have dramatically reduced deaths from this often fatal skin cancer. Leaders of a new study report that the death rate from ...
- Melanoma Isn't as Deadly as It Used to Beon March 19, 2020 at 1:52 pm
Between 2013 and 2016, the mortality rate for melanoma declined by almost 18 percent, according to a new study.
- Melanoma is killing fewest Americans in decadeson March 19, 2020 at 1:00 pm
Advances in treatment have led to the largest yearly declines in deaths due to melanoma ever recorded for this skin cancer, results of a new study suggest. Led by researchers at NYU Grossman School of ...
- Melanoma Cancer Market With Robust CAGR in Forecast Period 2020 to 2026on March 19, 2020 at 3:54 am
Melanoma Cancer is a skin cancer that develops due to expose of UV rays on the skin. Increasing incidence of melanoma across the globe and rising ozone layer depletion due to global warming are the ...
- 2019 Analysis of the Global Melanoma Treatment Market - ResearchAndMarkets.comon March 19, 2020 at 2:55 am
DUBLIN--(BUSINESS WIRE)--The "Global Melanoma Treatment Market Analysis 2019" report has been added to ResearchAndMarkets.com's offering. The Melanoma Treatment market is expected to reach $9.70 ...
- The use of circulating cell-free tumor DNA in routine diagnostics of metastatic melanoma patientson March 18, 2020 at 7:47 am
Modern advances in technology such as next-generation sequencing and digital PCR make detection of minor circulating cell-free tumor DNA amounts in blood from cancer patients possible. Samples can be ...
- OncoSec Announces Publication of Positive TAVO™ Monotherapy Results in Metastatic Melanoma Patients in Annals of Oncologyon March 17, 2020 at 5:30 am
SAN DIEGO and PENNINGTON, N.J., March 17, 2020 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a company developing late-stage intratumoral cancer ...
via Bing News